Australia/Canberra:
Pfizer Australia Pty Ltd. recalls certain batch/lots of Gentamicin Injection BP 80 mg due to suspected higher than expected amounts of Histamine, a serious health hazard. ACCC: http://ht.ly/m1ak30fLlIh
Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following Pfizer Australia Gentamicin are subject to this recall:
Filed under: ACCC, Antibiotics, Drugs, Labeling or regulatory issues, Medical / Veterinary | Tagged: ACCC, ACCC PRA number: 2017/16365, Anaphylaxis, Australian Competition & Consumer Commission, drug, medical, Pfizer Australia Pty Gentamicin Injection, Pfizer Australia Pty Ltd., Recalls Direct RIN: 9296-2017 | Leave a comment »